Usefulness of frailty profile for targeting older heart failure patients in disease management programs: a cost-effectiveness, pilot study

被引:76
|
作者
Pulignano, Giovanni [1 ]
Del Sindaco, Donatella [2 ]
Di Lenarda, Andrea [3 ]
Tarantini, Luigi [4 ]
Cioffi, Giovanni [5 ]
Gregori, Dario [6 ]
Tinti, Maria Denitza [1 ]
Monzo, Luca [1 ]
Minardi, Giovanni [1 ]
机构
[1] San Camillo Hosp, Heart Failure Clin, Div Cardiol, Coronary Care Unit, Trieste, Italy
[2] Inst Care & Res Elderly INRCA, Heart Failure Unit, Div Cardiol, Trieste, Italy
[3] Cardiovasc Ctr & Univ, Trieste, Italy
[4] San Martino Hosp, Heart Failure Clin, Div Cardiol, Belluno, Italy
[5] Villa Bianca Hosp, Heart Failure Clin, Div Cardiol, Trento, Italy
[6] Univ Turin, Dept Publ Hlth & Microbiol, Turin, Italy
关键词
cost-effectiveness; elderly; frailty; heart failure; management programs; ELDERLY-PATIENTS; FUNCTIONAL DECLINE; CARE; MULTIDISCIPLINARY; PREVENT; INTERVENTION; CARDIOLOGY; MORTALITY; ADMISSION; OUTCOMES;
D O I
10.2459/JCM.0b013e328339d981
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Disease management programs (DMP) improve outcomes in patients with heart failure. Because older heart failure patients represent a heterogeneous population, the aim of this study was to determine which patients benefit mostly from a DMP, by means of their frailty profile. Setting Heart failure outpatient clinic. Methods Consecutive (n = 173) patients aged more than 70 years were randomized to a multidisciplinary DMP (n = 86) or usual care (n = 87). A modified frailty score (range 1-6) was used as an index of global functional impairment. Results Mild to moderate frailty (frailty score = 2-3) was associated with significant improvements in outcomes (death and/or heart failure admission, heart failure admissions and all-cause admissions) in DMP patients vs. usual care. Even in more frail patients (frailty score = 4-6) a significant reduction in heart failure admissions was observed. By contrast, nonfrail patients (frailty score = 1) did not derive significant benefit. In the cost-effectiveness analysis, the mean savings per patient, stratified according to their frailty score, were (sic) -1003.31 for frailty score 1 (95% confidence interval -3717.00-1709.00), (sic) 1104.72 for frailty score 2 (-280.6-2491.00), (sic) 2635.42 for frailty score 3 (352.60-4917.00, P = 0.025) and (sic) 419.53 for frailty score 4-6 (-1909.00-2749.00). Intervention was therefore significantly cost saving in moderately frail, but not in nonfrail or severely frail patients. Thus, DMP was dominant (i.e. both less costly and more effective than usual care) in moderately frail patients. At sensitivity analysis, DMP remained dominant even to changes in cost of intervention and hospitalizations. Conclusion This suggests that an intensive, hospital-based DMP appears to be more effective in older patients with mild-to-moderate levels of frailty. Thus, a multidimensional assessment of frailty seems to be a useful tool for appropriate selection of model of care. J Cardiovasc Med 11: 739-747 (C) 2010 Italian Federation of Cardiology.
引用
收藏
页码:739 / 747
页数:9
相关论文
共 50 条
  • [21] The attitude towards disease management programs in Austrian heart failure patients: a pilot study comparing rural and urban patients
    Brandstetter, Clara
    Winter, Thomas
    Weidinger, Franz
    Stoellberger, Claudia
    MINERVA CARDIOANGIOLOGICA, 2020, 68 (03): : 209 - 215
  • [22] Effectiveness and Cost-Effectiveness of Case Management in Advanced Heart Failure Patients Attended in Primary Care: A Systematic Review and Meta-Analysis
    Checa, Caterina
    Canelo-Aybar, Carlos
    Suclupe, Stefanie
    Ginesta-Lopez, David
    Berenguera, Anna
    Castells, Xavier
    Brotons, Carlos
    Posso, Margarita
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (21)
  • [23] Cost-effectiveness of screening strategies to detect heart failure in patients with type 2 diabetes
    van Giessen, Anoukh
    Boonman-de Winter, Leandra J. M.
    Rutten, Frans H.
    Cramer, Maarten J.
    Landman, Marcel J.
    Liem, Anho H.
    Hoes, Arno W.
    Koffijberg, Hendrik
    CARDIOVASCULAR DIABETOLOGY, 2016, 15
  • [24] Cost-effectiveness analysis of pharmacist interventions in patients with heart failure in Thailand
    Arunmanakul, Poukwan
    Chaiyakunapruk, Nathorn
    Phrommintikul, Arintaya
    Ruengorn, Chidchanok
    Permsuwan, Unchalee
    JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2022, 62 (01) : 71 - 78
  • [25] COST-EFFECTIVENESS ANALYSIS OF IVABRADINE IN TREATMENT OF PATIENTS WITH HEART FAILURE IN IRAN
    Taheri, Saeed
    Heidari, Elham
    Aivazi, Mohammad Ali
    Shams-Beyranvand, Mehran
    Varmaghani, Mehdi
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2018, 34 (06) : 576 - 583
  • [26] Cost-effectiveness of immediate initiation of dapagliflozin in patients with a history of heart failure
    Miller, Robert J. H.
    Chew, Derek S.
    Qin, Lei
    Fine, Nowell M.
    Chen, Jieling
    McMurray, John J. V.
    Howlett, Jonathan G.
    McEwan, Phil
    EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 (02) : 238 - 247
  • [27] The cost-effectiveness of losartan versus captopril in patients with symptomatic heart failure
    Dasbach, EJ
    Rich, MW
    Segal, R
    Gerth, WC
    Carides, GW
    Cook, JR
    Murray, JF
    Snavely, DB
    Pitt, B
    CARDIOLOGY, 1999, 91 (03) : 189 - 194
  • [28] Cost-effectiveness analysis of sodium zirconium cyclosilicate for hyperkalemia among patients with chronic kidney disease or heart failure in Kuwait
    Elsisi, Gihan Hamdy
    Mahmoud, Mohamed M. Ibrahim
    Al-Humood, Khaldoon
    Al-Yousef, Anas
    JOURNAL OF MEDICAL ECONOMICS, 2024, 27 (01) : 253 - 265
  • [29] Cost-Effectiveness of Multidisciplinary Management Program and Exercise Training Program in Heart Failure
    Dang, Weixiong
    Yi, Anji
    Jhamnani, Sunny
    Wang, Shi-Yi
    AMERICAN JOURNAL OF CARDIOLOGY, 2017, 120 (08) : 1338 - 1343
  • [30] The simpler modified fried frailty scale predicts 2-year mortality in older adults with heart failure: a pilot study
    Kucuk, Celalettin
    Ozkok, Serdar
    Bahat, Gulistan
    Karaayvaz, Ekrem Bilal
    Altinkaynak, Mustafa
    Medetalibeyoglu, Alpay
    Karan, Mehmet Akif
    BMC GERIATRICS, 2025, 25 (01)